Middle East Pharmaceutical Industries 配当金
配当金 基準チェック /26
Middle East Pharmaceutical Industries is a dividend paying company with a current yield of 1.13% that is well covered by earnings.
主要情報
1.1%
配当利回り
n/a
バイバック利回り
| 総株主利回り | n/a |
| 将来の配当利回り | 1.1% |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | ر.س1.500 |
| 配当性向 | 19% |
最近の配当金アップデート
更新なし
Recent updates
決済の安定と成長
配当データの取得
安定した配当: Too early to tell whether 4016's dividend payments have been stable as they only just started paying a dividend.
増加する配当: Too early to tell if 4016's dividend payments are increasing as they only just started paying a dividend.
配当利回り対市場
| Middle East Pharmaceutical Industries 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (4016) | 1.1% |
| 市場下位25% (SA) | 1.8% |
| 市場トップ25% (SA) | 4.6% |
| 業界平均 (Pharmaceuticals) | 1.8% |
| アナリスト予想 (4016) (最長3年) | 1.1% |
注目すべき配当: 4016's dividend (1.13%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.83%).
高配当: 4016's dividend (1.13%) is low compared to the top 25% of dividend payers in the SA market (4.61%).
株主への利益配当
収益カバレッジ: With its low payout ratio (18.9%), 4016's dividend payments are well covered by earnings.
株主配当金
キャッシュフローカバレッジ: With its reasonably low cash payout ratio (41%), 4016's dividend payments are well covered by cash flows.